Cite
MLA Citation
J. Pope et al.. “THU0169 Persistence of Tofacitinib in The Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up To 7 Years.” Annals of the rheumatic diseases, vol. 75, n.d., p. 245. http://access.bl.uk/ark:/81055/vdc_100135149463.0x000056